AMBFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
RLBEX
Price
$38.94
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

AMBFX vs RLBEX

Header iconAMBFX vs RLBEX Comparison
Open Charts AMBFX vs RLBEXBanner chart's image
American Funds American Balanced F2
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
American Funds American Balanced R4
Price$38.94
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
AMBFX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
AMBFX vs. RLBEX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMBFX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AMBFX (265B) and RLBEX (265B) have equal amount of cash in the bank . AMBFX pays higher dividends than RLBEX: AMBFX (1.95) vs RLBEX (1.74). AMBFX was incepted earlier than RLBEX: AMBFX (17 years) vs RLBEX (23 years). RLBEX (0.59) is less costly to investors than AMBFX (0.35). AMBFX (44.00) and RLBEX (44.00) have comparable annual turnover. AMBFX (250) and RLBEX (250) have matching initial minimum investment requirements. AMBFX (8.95) and RLBEX (8.70) have marching annual gain over last year. AMBFX (43.52) and RLBEX (42.04) have equivalent 5 years return.
AMBFXRLBEXAMBFX / RLBEX
Total Expense Ratio0.350.5959%
Annual Report Gross Expense Ratio0.350.5959%
Fund Existence17 years23 years-
Gain YTD14.81414.631101%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets265B265B100%
Annual Yield % from dividends1.951.74112%
Returns for 1 year8.958.70103%
Returns for 3 years51.5850.52102%
Returns for 5 years43.5242.04104%
Returns for 10 years78.0277.69100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN24.211.20
+5.22%
Viridian Therapeutics
PRTC18.000.46
+2.65%
PureTech Health plc
GTBP0.690.01
+1.38%
GT Biopharma
POOL290.210.04
+0.01%
Pool Corp
CATO3.89N/A
N/A
CATO Corp